Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Recruiting

Studying Health Outcomes After Treatment in Patients With Retinoblastoma

NCT03932786

Conditions: Biological Sibling, Cancer Survivor, Eye Diseases, +15 more
Locations: Lurie Children's Hospital Chicago, Illinois, United States

University of Illinois, Chicago Chicago, Illinois, United States

University of Minnesoa Minneapolis, Minnesota, United States

Washington School of Medicine at St. Louis St Louis, Missouri, United States

View Trial Details

Recruiting

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

NCT01205815

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Vanderbitl-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial

NCT06835803

Conditions: Astrocytoma, Glioblastoma, Glioblastoma (GBM), +8 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Brigham Cancer Center, Milford Hospital Milford, Massachusetts, United States

Dana-Farber Brigham Cancer Center, South Shore Hospital South Weymouth, Massachusetts, United States

View Trial Details

Recruiting

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

NCT06505824

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +13 more
Locations: Shanghai East Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients

NCT06906822

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Complexo Hospitalario Universitario de A Coruña A Coruña, Spain

Institut Català D'Oncologia - Badalona Badalona, Barcelona, Spain

Hospital Universitari Dexeus Barcelona, Spain

Hospital Universitario Valle de Hebrón Barcelona, Spain

View all 13 locations

View Trial Details

Recruiting

Naltrexone and Propranolol Combined With Immunotherapy

NCT05968690

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Recruiting

Personalised Immunotherapy Platform

NCT06536257

Conditions: Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +25 more
Locations: Chris O'Brien Lifehouse Sydney, New South Wales, Australia

Melanoma Institute Australia Sydney, New South Wales, Australia

Westmead Hospital Sydney, New South Wales, Australia

View Trial Details

Recruiting

DLL3 CAR-T Therapy Targeting Brain Tumors

NCT07180927

Conditions: Astrocytoma, Glioblastoma, Glioblastoma of Cerebellum, +8 more
Locations: Shenzhen Geno-immuno Medical Institute Shenzhen, Guangdong, China

View Trial Details

Recruiting

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

NCT07179328

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +21 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

NCT05839912

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Emory University Atlanta, Georgia, United States

University of Maryland Baltimore, Maryland, United States

University of Michigan Ann Arbor, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions